Over the years, different methods have been developed to overcome these limitations and to maintain EGFR amplification in addition to a stem-like phenotype in vitro, which allowed for the investigation of the contribution of the EGF/EGFR axis to a glioma stem cell phenotype in an EGFR-amplified background. This evidence concerns the gene EGFR and glioma.